Global Psychedelic Drugs Market – Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Published Report
  • Mar 2021
  • Global
  • 350 Pages
  • No of Tables: 225
  • No of Figures: 73

Global Psychedelic Drugs Market, By Source (Synthetic, Natural), Type (Empathogens, Dissociatives, Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin, Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, Others), Route of Administration (Oral, Inhalation, Injectable), End User (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Belgium, Lithuania, rest of Europe, Saudi Arabia, UAE, Israel and Egypt) Industry Trends and Forecast to 2028

 Psychedelic Drugs Market Global Market Analysis and Insights: Global Psychedelic Drugs Market

The psychedelic drugs market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 13.3% in the forecast period of 2021 to 2028 and is expected to reach USD 7,567.52 million by 2028 from USD 2,823.67 million in 2020. The rising prevalence of mental depression and anxiety and availability of off-label drugs are the major drivers which has propelled the demand of the psychedelic drugs market in the forecast period.

Psychedelic drugs involve various types of chemical substances including LSD and chemical extracted from plants. Psychedelic drugs have the ability to change or enhance the senosory perceptions, thought processes, energy levels and have also been reported to facilitate spiritual experiences. Psychedelic drugs can be categorized into empathogens and dissociative drugs (such as PCP) and serotonergic (classic hallucinogens) such as LSD.

The awareness campaigns have encouraged people to select appropriate treatment for mental disorders procedures and professionals which is increasing the demand of psychedelic drugs and the rising awareness towards mental health is acting as a driver for the psychedelic drugs market. Changes in the regulation charges for psychedelic drugs approval and taking regulatory approval could lead to delay product launch and stringent regulatory is working as a restraint for the psychedelic drugs market. Increasing research and development expenditure in the psychedelic drugs is creating new opportunities in the psychedelic drugs market, thus increasing R&D activities in psychedelic drugs is acting as an opportunity for the growth of the psychedelic drugs market. The increasing side effects of the psychedelic drugs act as a challenge for the growth of the psychedelic drugs market in the forecasted period.

The psychedelic drugs market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the psychedelic drugs market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

 Psychedelic Drugs Market Global Psychedelic Drugs Market Scope and Market Size

The psychedelic drugs market is segmented into seven notable segments which are based on the source, type, drugs, application, route of administration, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of source, the psychedelic drugs market is segmented into synthetic and natural. In 2021, synthetic segment is dominating as most of the products are made from chemicals that are man-made with very few products such as psilocybin made from natural ingredients.
  • On the basis of type, the psychedelic drugs market is segmented into dissociatives, empathogens and others. In 2021, empathogens segment produce experiences of emotional communion, oneness, relatedness and used for treatment of cataplexy, narcolepsy and related disorders.
  • On the basis of drugs, the psychedelic drugs market is segmented into gamma-hydroxybutyric acid, ketamine, psilocybin and others. In 2021, gamma-hydroxybutyric acid segment is dominating as xyrem from Jazz Pharmaceutical is one of the oldest available psychedelic drugs available in the market holding a major share and belongs to the drug class.
  • On the basis of application, the psychedelic drugs market is segmented into narcolepsy, treatment resistant depression, post-traumatic stress disorder, major depressive disorder, opiate addiction and others. In 2021, narcolepsy segment is dominating as xyrem from Jazz Pharmaceutical is used for its treatment and it is the major shareholder in the market.
  • On the basis of route of administration, the psychedelic drugs market is segmented into oral, inhalation and injectable. In 2021, oral segment is dominating as it is preferred over the various other administration routes of drug delivery.
  • On the basis of end user, the psychedelic drugs market is segmented into hospitals, specialty clinics, homecare and others. In 2021, hospitals segment dominate the psychedelic drugs market due to the high patient load and most of the drugs are given under doctor’s supervision.
  • On the basis of distribution channel, the psychedelic drugs market is segmented into hospitals pharmacy, retail pharmacy and online pharmacy. In 2021, hospitals pharmacy segment holds the largest market share as more number of patients is treated in hospitals and the demand for medicines in hospital pharmacy increases.

 Psychedelic Drugs Market Global Psychedelic Drugs Market Country Level Analysis

The psychedelic drugs market is analysed and market size information is based on the country, source, type, drugs, application, route of administration, end user and distribution channel as referenced above.

The countries covered in the psychedelic drugs market report are the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Belgium, Lithuania, rest of Europe, Saudi Arabia, UAE, Israel and Egypt.

In North America, the U.S. is dominating the market due to growing acceptance of psychedelic drugs for treating depression and rise in product approvals. However, In Europe, Germany is dominating the market due to rising awareness towards mental health. Whereas, Saudi Arabia is dominating in Middle East and Africa due to ongoing clinical trials and increasing prevalence of depression and mental disorders in the country.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Strategic Initiatives by Manufacturers is Creating New Opportunities for Players in the Psychedelic Drugs Market

The psychedelic drugs market also provides you with detailed market analysis for every country growth in aesthetic industry with psychedelic drugs sales, impact of advancement in the psychedelic drugs and changes in regulatory scenarios with their support for the psychedelic drugs market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Global Psychedelic Drugs Market Share Analysis

The psychedelic drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus.

The major companies providing psychedelic drugs are Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.), Hikma Pharmaceuticals PLC, COMPASS, Verrian, Pfizer Inc., F. Hoffmann-La Roche Ltd, Jazz Pharmaceuticals, Inc., PharmaTher Inc., Avadel, Celon Pharma S.A., NeuroRx, Inc., usonainstitute.org among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the global psychedelic drugs market.

For instance,

  • In August 2020, Janssen Pharmaceuticals, Inc. received approval for its Spravato nasal spray for treatment of suicidal people. As per the data published, approximately 11% to 12% of Americans suffers from major depressive disorder that led them to commit suicide. Hence, this approval provided these patients with a remarkable therapy and allowed company to generate more revenue.
  • In January 2020, Jazz Pharmaceuticals, Inc. has received the marketing authorization of solriamfetol (Sunosi) indicated for treatment of excessive daytime sleepiness in adults with narcolepsy. This authorization allowed the company to enhance product distribution network and to generate more revenue in the market.

Collaboration, joint ventures and other strategies by the market players is enhancing the company market in the psychedelic drugs market which also provides the benefit for organisation to improve their offering for psychedelic drugs.

Customization Available: Global Psychedelic Drugs Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES 

TABLE 1 U.S. PSYCHEDELIC DRUGS MARKET, COMPANY WISE PIPELINE ANALYSIS

TABLE 2 U.S. PSYCHEDELIC DRUGS MARKET, RESEARCH INSTITUTE PIPELINE ANALYSIS

TABLE 3 PSYCHEDELICS RESEARCHES, IN EUROPE

TABLE 4 MENTAL ILLNESS IN THE U.S. ADULTS, IN 2018

TABLE 5 MENTAL DISORDERS, IN THE U.S. ADULTS, IN 2018

TABLE 6 MORE THAN ONE IN SIX PEOPLE IN EU COUNTRIES HAVE A MENTAL HEALTH PROBLEM

TABLE 7 MEN ARE MORE LIKELY TO DIE FROM SUICIDE, IN ALL EU COUNTRIES

TABLE 8 MENTAL DISORDERS CAUSED BY USAGE OF SUBSTANCE DISORDERS, IN WORLD, IN 2017

TABLE 9 DRUG DEVELOPMENT PATHWAY FOR FDA APPROVAL OF NEW MEDICATIONS

TABLE 10 THE 1971 UN CONVENTION ON PSYCHOTROPIC SUBSTANCES

TABLE 11 COST OF PSYCHEDELIC DRUGS

TABLE 12 TOTAL COSTS (DIRECT AND INDIRECT) OF MENTAL HEALTH PROBLEMS IN EU COUNTRIES, IN MILLION AND AS A SHARE OF GDP, IN 2015

TABLE 13 PSYCHEDELIC DRUGS R&D ACTIVITIES

TABLE 14 GLOBAL PSYCHEDELIC DRUG MARKET, BY SOURCE 2020-2028 (USD MILLION)

TABLE 15 GLOBAL SYNTHETIC IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 GLOBAL NATURAL IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 GLOBAL PSYCHEDELIC DRUG MARKET, BY TYPE, 2020-2028 (USD MILLION)

TABLE 18 GLOBAL EMPATHOGENS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 GLOBAL DISSOCIATIVES IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 GLOBAL OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 GLOBAL THERAPY IN PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 22 GLOBAL GAMMA-HYDROXYBUTYRIC ACID IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 GLOBAL KETAMINE IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 GLOBAL PSILOCYBIN IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 GLOBAL OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 GLOBAL APPLICATION IN PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 27 GLOBAL NARCOLEPSY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 GLOBAL TREATMENT RESISTANT DEPRESSION IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 GLOBAL MAJOR DEPRESSIVE DISORDER IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 GLOBAL OPIATE ADDICTION IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 GLOBAL POST-TRAUMATIC STRESS DISORDER IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 GLOBAL OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 GLOBAL PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 34 GLOBAL ORAL IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 GLOBAL INHALATION IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 GLOBAL INJECTABLE IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 37 GLOBAL PSYCHEDELIC DRUG MARKET, BY END USER, 2020-2028 (USD MILLION)

TABLE 38 GLOBAL HOSPITALS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 39 GLOBAL SPECIALTY CLINICS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 40 GLOBAL HOMECARE IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 41 GLOBAL OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 42 GLOBAL MEDICATION & SUPPLEMENTS IN PSYCHEDELIC DRUG MARKET, BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)

TABLE 43 GLOBAL HOPITALS PHARMACY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 44 GLOBAL RETAIL PHARMACY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 45 GLOBAL ONLINE PHARMACY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 46 GLOBAL PSYCHEDELIC DRUGS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 47 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 48 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 49 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 50 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 51 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 52 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 53 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 54 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 55 U.S.PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 56 U.S. PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 57 U.S. PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 58 U.S. PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 59 U.S. PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 60 U.S. PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 61 U.S. PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 62 CANADA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 63 CANADA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 64 CANADA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 65 CANADA PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 66 CANADA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 67 CANADA PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 68 CANADA PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 69 MEXICO PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 70 MEXICO PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 71 MEXICO PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 72 MEXICO PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 73 MEXICO PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 74 MEXICO PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 75 MEXICO PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 76 EUROPE PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 77 EUROPE PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 78 EUROPE PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 79 EUROPE PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 80 EUROPE PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 81 EUROPE PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 82 EUROPE PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 83 EUROPE PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 84 GERMANY PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 85 GERMANY PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 86 GERMANY PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 87 GERMANY PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 88 GERMANY PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 89 GERMANY PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 90 GERMANY PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 91 U.K. PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 92 U.K. PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 93 U.K. PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 94 U.K. PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 95 U.K. PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 96 U.K. PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 97 U.K. PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 98 FRANCE PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 99 FRANCE PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 100 FRANCE PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 101 FRANCE PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 102 FRANCE PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 103 FRANCE PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 104 FRANCE PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 105 ITALY PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 106 ITALY PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 107 ITALY PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 108 ITALY PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 109 ITALY PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 110 ITALY PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 111 ITALY PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 112 SPAIN PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 113 SPAIN PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 114 SPAIN PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 115 SPAIN PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 116 SPAIN PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 117 SPAIN PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 118 SPAIN PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 119 RUSSIA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 120 RUSSIA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 121 RUSSIA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 122 RUSSIA PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 123 RUSSIA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 124 RUSSIA PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 125 RUSSIA PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 126 POLAND PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 127 POLAND PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 128 POLAND PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 129 POLAND PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 130 POLAND PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 131 POLAND PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 132 POLAND PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 133 SWITZERLAND PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 134 SWITZERLAND PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 135 SWITZERLAND PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 136 SWITZERLAND PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 137 SWITZERLAND PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 138 SWITZERLAND PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 139 SWITZERLAND PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 140 NETHERLANDS PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 141 NETHERLANDS PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 142 NETHERLANDS PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 143 NETHERLANDS PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 144 NETHERLANDS PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 145 NETHERLANDS PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 146 NETHERLANDS PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 147 HUNGARY PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 148 HUNGARY PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 149 HUNGARY PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 150 HUNGARY PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 151 HUNGARY PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 152 HUNGARY PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 153 HUNGARY PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 154 AUSTRIA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 155 AUSTRIA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 156 AUSTRIA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 157 AUSTRIA PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 158 AUSTRIA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 159 AUSTRIA PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 160 AUSTRIA PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 161 NORWAY PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 162 NORWAY PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 163 NORWAY PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 164 NORWAY PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 165 NORWAY PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 166 NORWAY PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 167 NORWAY PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 168 IRELAND PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 169 IRELAND PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 170 IRELAND PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 171 IRELAND PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 172 IRELAND PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 173 IRELAND PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 174 IRELAND PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 175 BELGIUM PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 176 BELGIUM PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 177 BELGIUM PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 178 BELGIUM PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 179 BELGIUM PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 180 BELGIUM PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 181 BELGIUM PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 182 LITHUANIA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 183 LITHUANIA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 184 LITHUANIA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 185 LITHUANIA PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 186 LITHUANIA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 187 LITHUANIA PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 188 LITHUANIA PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 189 REST OF EUROPE PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 190 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 191 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 192 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 193 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 194 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 195 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 196 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 197 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 198 SAUDI ATRABIA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 199 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 200 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 201 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 202 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 203 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 204 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 205 ISRAEL PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 206 ISRAEL PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 207 ISRAEL PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 208 ISRAEL PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 209 ISRAEL PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 210 ISRAEL PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 211 ISRAEL PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 212 EGYPT PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 213 EGYPT PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 214 EGYPT PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 215 EGYPT PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 216 EGYPT PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 217 EGYPT PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 218 EGYPT PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 219 UAE PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 220 UAE PSYCHEDELIC DRUGS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 221 UAE PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2019-2028 (USD MILLION)

TABLE 222 UAE PSYCHEDELIC DRUGS MARKET, BY APPLICATION , 2019-2028 (USD MILLION)

TABLE 223 UAE PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 224 UAE PSYCHEDELIC DRUGS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 225 UAE PSYCHEDELIC DRUGS MARKET, BY DISTRUBUTION CHANNEL, 2019-2028 (USD MILLION)

 

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions